Cardinal Health, Inc. (CAH)

NYQ · Health Care · Medical Distribution
By Alex · Tickerpine
$237.92
+3.17 (+1.35%)
Price — last 10 years monthly, dividend-adjusted · hover for detail
Market Cap
$55.72B
P/E (TTM)
36.4
Forward P/E
19.8
EPS (TTM)
$6.54
ROE
Profit Margin
0.62%
Revenue Growth
11.00%
Dividend Yield
0.86%
Beta
0.53
52W High
$240.44
52W Low
$137.75
Analyst Target
$245.27
What would an investment in CAH be worth today?
Run CAH through our free historical return calculator.
Calculate CAH returns →

Congress trading in CAH

11 members of Congress have disclosed trading CAH — 10 purchases and 4 sales worth an estimated $346,000. Most recent disclosure: Apr 8, 2025.

See who in Congress traded CAH →

About Cardinal Health, Inc.

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Company website ↗

CAH Key Statistics

Previous Close$234.75P/E Ratio36.4
Market Cap$55.72BPEG Ratio1.47
Revenue (TTM)$250.74BROE
Gross Margin3.76%ROA3.60%
Debt / EquityEmployees53,084

CAH in plain English

Compare CAH with peers

CAH vs LLYEli Lilly and Company $1,208.12 CAH vs JNJJohnson & Johnson $254.66 CAH vs ABBVAbbVie Inc. $253.35 CAH vs UNHUnitedHealth Group Incorporated $427.89 CAH vs MRKMerck & Co., Inc. $128.66

Data last refreshed from public sources. Figures may be delayed. Not investment advice.